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We investigated the nasopharynx and oropharynx microbiota in sickle cell disease (SCD)
to identify the microorganisms, antibiotic sensitivity, prevalent serotypes, and association
of with laboratorial markers. Oropharynx/nasopharynx secretions were investigated
in 143 SCD children aging 6 months to 17 years. Pathogens were isolated using
standard procedures, and laboratorial markers were performed by automated methods.
Staphylococcus aureus (S. aureus) was isolated from nasopharynx and oropharynx of
64 and of 17 SCD children respectively. Streptococcus pneumoniae (S. pneumoniae)
was isolated from the nasopharynx and oropharynx of eight SCD patients. Serotypes
of S. pneumoniae were 19F, 23F, and 14. All isolates were susceptible to penicillin,
and patients whose nasopharynx and oropharynx were colonized by S. pneumoniae
had high concentrations of aspartate transaminase, alanine transaminase, and ferritin.
S. pneumoniae isolated were not penicillin-resistant serotypes suggesting that the use of
penicillin for prophylaxis and/or treatment of infections is safe. Our finding of colonization
and laboratory evaluation in SCD patients suggests that microorganisms are involved in
the modulation of chronic inflammatory. The association of colonized microorganisms
and laboratorial markers suggest a new approach to these patients follow-up, and
additional studies of microorganism colonization and their association with SCD patients’
clinical outcome will improve control and prevention strategies.
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INTRODUCTION
Infections are the major cause of death in children with sickle cell anemia (SCA) (Williams
et al., 2009). Likewise, bacterial infection is the primary cause of death during childhood; infants
and children younger than 3 years of age are at risk of mortality and morbidity from sepsis
(Iughetti et al., 2016). Streptococcus pneumoniae (S. pneumoniae) is a genetically variable organism
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that colonizes the human upper respiratory mucosa coexisting
with the normal microbiota and establishing a state of
asymptomatic colonization (Cardozo et al., 2006; Mitchell and
Mitchell, 2014). S. pneumoniae is an epidemiologically important
pathogen with a worldwide distribution that causes invasive (i.e.,
pneumonia, bacteraemia, meningitis, sepsis, and arthritis) and
non-invasive diseases (i.e., sinusitis, otitis media, conjunctivitis,
bronchitis, and pneumonia) (Bogaert et al., 2004b; World Health
Organization, 2007; Liñares et al., 2010). Staphylococcus aureus
(S. aureus) infections have recently increased and represent a
public health problem in the United States of America (USA)
(Bogaert et al., 2004b; Fridkin et al., 2005; Kuehnert et al., 2006).
S. aureus causes pneumonia, sepsis and osteo-articular, skin, and
soft tissue infections (Gonzalez et al., 2005; Moran et al., 2005;
Kuehnert et al., 2006). The growing number of community-
acquired infections caused by methicillin-resistant S. aureus in
children and healthy adults is a major problem (Fridkin et al.,
2005; Gonzalez et al., 2005; Kuehnert et al., 2006), particularly in
countries such as Brazil, where nasal carriage prevalence (48%)
(Braga et al., 2014) is higher than those described in other
countries of Latin America (Gardella et al., 2011).
Pneumococcal conjugate vaccine has minimal impact on
overall carriage rate due to non-vaccine serotypes replacement,
but could influence others bacterial species in the nasopharynx
(Shak et al., 2013). It has been described after immunization
by the 7-valent pneumococcal vaccine an inverse relationship
between nasopharyngeal carriage of vaccine type S. pneumoniae
and S. aureus, as well as an increase of infections, especially acute
otitis media (Ferreira et al., 2001; Bogaert et al., 2004a; Moran
et al., 2005; Kuehnert et al., 2006). Thus, the colonization of
the upper respiratory tract may be an important factor in the
occurrence of local or systemic disease among SCD patients.
Studies assessing the prevalence of pneumococcal
nasopharyngeal colonization demonstrate that the presence
of these bacteria may be influenced by several factors, such as
age, genetic background, geographic area, and environmental
conditions (Ferreira et al., 2001; Bogaert et al., 2004b). Fonseca
et al. (2005) evaluated 98 children with SCD in the Brazilian
state of Sao Paulo and found that the nasopharynx was
colonized by pneumococcus in 13.3% of children. In the
USA, the rate of nasopharyngeal colonization in SCD patients
ranges from 5 to 17% (Anglin et al., 1984; Steele et al., 1996).
Previous studies have described the exposure of these bacteria
to penicillin and the selection of antibiotic resistant strains
(Denno et al., 2002). However, previous studies assessing
penicillin resistance in children with SCD who regularly use
penicillin have reported controversial results. Norris et al. (1996)
found that 33% of pneumococcus was penicillin-resistant and
that 36% of these strains exhibited high resistance. However,
Fonseca et al. (2005) found no strains that exhibited high
resistance to penicillin. The aims of the present study were to
evaluate the nasopharynx/oropharynx colonization in Brazilian
children with SCD, identify the penicillin sensitivity profile
among S. pneumoniae-colonized patients; describe the most
prevalent serotypes causing invasive diseases. Furthermore, we
described the association of microorganisms’ colonization with
biochemical laboratorial markers.
MATERIALS AND METHODS
This study was conducted with 143 SCD patients, aged from
6 months to 17 years, who were prospectively selected from
the outpatients at the pediatric hematology department of the
Fundação de Hematologia e Hemoterapia do Estado da Bahia
(HEMOBA), which is a reference center for clinical assistance,
from March to December 2010. All the involved patients were
from Bahia, a state on Northeast Brazil and the majority of
patients lived in Salvador (state capital) or metropolitan area. All
SCD patients were in a steady state, which was characterized by
the absence of acute clinical events, infections or inflammatory
episodes, and did not undergo any blood transfusion procedures
prior to sampling.
Nasopharyngeal and oropharyngeal swabs samples were
collected by a researcher on the day of the interview. Additional,
clinical and epidemiological information were collected using
questionnaires after interviews with the parents; this information
was supplemented with information contained in the medical
records, such as age, gender, race, SCD genotype (i.e., HbSS and
HbSC), prophylaxis, vaccination with the pneumococcal 7-valent
and 23-valent vaccines, and laboratory data (i.e., blood cell count,
evidence of haemolysis, and evaluation of inflammation).
Nasopharyngeal material was collected during the patients’
routine clinic visits using sterile swabs, which were introduced
carefully into the right and left nostrils to a depth equal to two-
thirds of the distance between the nose and ear lobe (Norris et al.,
1996). After the nasopharynx material was collected, another
swab was used to collect oropharynx material. Each swab was
subsequently immersed in media for bacterial transport and was
sent (at room temperature) to the bacteriology laboratory of the
Faculdade de Farmácia at the Universidade Federal da Bahia
within 1–2 h of collection.
Collected material was inoculated onto blood agar plates
containing 5% sheep blood and was incubated at 36 ± 1◦C with
a 5–10% CO2 atmosphere. The presence of a gray-green zone
around the colonies (i.e., alpha-haemolysis) was presumptive
of S. pneumoniae. Confirmation was obtained using the rapid
agglutination test with latex particles and by evaluating the
inhibitory zone around Optochin differentiation disks; when
necessary, the bile solubility test was also performed. Other
bacteria were identified using the Grammethod to analyse colony
characteristics, such as size, color, shape, growth on selective
media, and subsequent analysis of biochemical and metabolic
activities.
Evaluation of susceptibility to penicillin was performed using
the disk diffusion method with oxacillin (1 µg) according
to Clinical and Laboratory Standards Institute guidelines
(Clinical Laboratory Standards Institute (CLSI), 2012). When
the inhibitory zone was >20 mm, the microorganism sample
was considered penicillin-susceptible, and when the inhibitory
zone was<19mm, themicroorganismwas considered penicillin-
resistant. The minimum inhibitory concentration (MIC) for
penicillin was determined using the E-test in all pneumococcal
strains resistant to oxacillin (i.e., halo <19 mm). The MIC
for penicillin was interpreted as susceptible when the obtained
value was <0.06 mg/mL; intermediate when the obtained
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value was 0.1–1 mg/mL; and resistant when the obtained
value was > 2.0 µg/mL (Liñares et al., 2010). Bacterial
resistance was also determined for erythromycin, trimethoprim-
sulfamethoxazole, clindamycin, and cefotaxime. Serotyping of
the isolated pneumococcal strains was performed using the
Quellung Neufeld reaction with antisera produced at the Statem
Serum Institute in Copenhagen, Denmark.
Chemical and immunological markers were evaluated
by immunochemistry and with the A25 Immunoassay
system (Biosystems SA, Costa Brava, Barcelona, Spain),
the Access R© 2 Immunoassay system X2 (Beckman Coulter,
Inc., Fullerton, CA, USA) and the Immage R© 800 system
(Beckman Coulter, Fullerton, CA, USA). Haematological
parameters were quantified using an electronic cell counter
(Coulter Corporation, FL, USA), and hemoglobin (Hb)
patterns were investigated using high performance liquid
chromatography (HPLC) (Bio-Rad Variant-I; Bio-Rad, Hercules,
CA, USA).
Statistical Analysis
The distribution of quantitative variables was evaluated using
the Kolmogorov-Smirnov test. The Mann-Whitney test and
the unpaired Student’s t-test were used to estimate differences
in hematological and chemical markers among steady-state
SCD children with and without nasopharynx/oropharynx
colonization. Differences were considered significant when the p-
values were <0.05. The statistical analyses were performed using
EPI info 6.04 (Centers for Disease Control & Prevention (CDC),
Atlanta, GA, United States) and Graphpad Prism Software 5.01
(San Diego, CA).
Multivariate analyses were performed to estimate the
likelihood of having pneumonia and infection as outcome
(dependent variable) and a possible interaction with oropharynx
colonization, neutrophils count, leukocytes count, platelets
count, hemoglobin profile, reticulocytes count, and nasopharynx
colonization as independent variables, adjusted for sex
and age.
ETHICS STATEMENT
All children’s guardians agreed to participate in the study
after reading the terms of informed consent and signing the
consent form. After that, the material was collected. The human
subject research board of the Centro de Pesquisas Gonçalo
Moniz- Fundação Oswaldo Cruz- Bahia (CPqGM-FIOCRUZ-
BA) approved the study (CAAE 0031.0.225.000-06). The study
was performed after obtaining written consent and followed the
Brazilian standards for the development of research on humans.
This work was conducted in accordance with the Helsinki
Declaration of 1975, as revised in 1983.
RESULTS
A total of 143 SCD patients were investigated; 44/143 (30.8%) had
SC disease (i.e., HbSC), and 99/143 (69.2%) had sickle cell anemia
(SCA). The distribution according to sex was 66/143 (46.1%)
female patients and 77/143 (53.9%) male patients. The average
age of the SCD patients was 9.25 ± a standard deviation (SD) of
4.06 years. Also, 41/143 (28.6%) patients were less than or equal
to 5 years old, and 102/143 (71.4%) patients were over 5 years old.
Clinical manifestations of SCD patients are presented on Table 1.
We identified that 85.3% (122/143) of the patients received
the pneumococcal 7-valent conjugate vaccine, through the public
health Brazilian system. Approximately 14% (14.7%) (21/143)
were not vaccinated or received at least one of the three
commonly available doses.
Haematological and chemical markers were evaluated in the
SCD patients (Table 2). The oropharynx/nasopharynx culture
procedure enabled the collection of various microorganisms with
an emphasis on S. aureus and S. pneumoniae. Pneumococcus
was isolated from the nasopharynx/oropharynx in 16 of 143
children representing a colonization rate of 11.2%. One child
with pneumococcal colonization was colonized by two different
serogroups (Table 3).
All children under 6 years of age used prophylactic penicillin
and received pneumococcal vaccines according to the expected
age. None of the pneumococcal isolates exhibited resistance to
penicillin. Serotypes and their antibiotic susceptibility are shown
in Table 4.
An analysis of the association of hematological and chemical
markers with nasopharynx and oropharynx colonization
revealed a significant association between ferritin (ng/mL) and
oropharyngeal colonization by S. aureus and S. pneumoniae with
a mean and SD of 245.1± 240.8 for subjects colonized by normal
microbiota (91/143); 627.6 ± 624.4 for individuals colonized
by S. pneumoniae (8/143); and 460.6 ± 148.8 for individuals
colonized by S. aureus (17/143) (p = 0.0016). The analysis also
revealed significant differences in ferritin between individuals
colonized by normal microbiota and individuals colonized by
S. aureus (p = 0.0144) and between individuals colonized by
normal microbiota and individuals colonized by S. pneumoniae
(p < 0.0001) (Figure 1).
A statistical analysis of the association between biochemical
markers and the presence of nasopharyngeal colonization by
S. aureus and S. pneumoniae revealed significant differences in
ferritin with a mean and standard deviation of 324.0 ± 46.06
for subjects who were colonized by normal microbiota (69/143),
383.1± 336.8 for individuals colonized by S. aureus (64/143), and
1144± 641.8 for individuals colonized by S. pneumoniae (8/143)
TABLE 1 | Clinical manifestations of SCD patients.
Clinical event Sickle cell
disease patients
N (%)
Sickle cell
anemia patients
N (%)
SC disease
patients
N (%)
Hospitalization 117/143 (81.8) 85/99 (85.8) 32/44 (72.7)
Pneumonia 77/143 (53.8) 65/99 (65.6) 12/44 (27.2)
Splenomegaly 21/143 (14.7) 16/99 (16.2) 5/44 (11.4)
Splenic sequestration 18/143 (12.6) 17/99 (17.2) 1/44 (2.2)
Stroke 8/143 (5.6) 7/99 (7.1) 1/44 (2.2)
Vaso-occlusion 119/143 (83.2) 83/99 (83.8) 36/44 (81.8)
Infection 66/143 (46.1) 48/99 (48.5) 18/44 (40.9)
Gallstones 8/143 (5.6) 7/99 (7.1) 1/44 (2.2)
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TABLE 2 | Distribution of variables associated with lipid, renal, and hepatic metabolism; haemolysis; and inflammation in patients with sickle cell disease
(SCD).
Markers SCD Patients (N) 143 Mean ± SD 25th percentile Median 75th percentile
HEMATOLOGICAL
RBC, millions/mL 3.23 ± 0.97 2.47 2.95 3.99
Hemoglobin, g/dL 8.92 ± 2.00 7.40 8.50 10.50
Hematocrit, % 27.60 ± 6.20 22.80 26.35 32.92
MCV, fL 87.52 ± 10.81 79.17 87.80 94.93
MCH, pg 28.35 ± 3.75 25.47 28.70 31.00
MCHC, % 32.36 ± 0.99 31.70 32.30 32.90
Reticulocytes, % 7.62 ± 4.84 3.15 6.95 11.22
Erythroblasts 1.61 ± 2.38 – 1.00 2.00
HEMOGLOBIN PATTERN
Hemoglobin S, % 75.23 ± 17.23 56.25 83.10 90.30
Hemoglobin Fetal, % 7.49 ± 6.19 2.70 5.60 10.93
WHITE BLOOD CELLS
WBC, × 109/L 13081.82 ± 5744.83 9475.00 12400.00 15650.00
Neutrophils, × 109/L 6128.33 ± 3801.37 3720.00 5171.00 7648.50
Monocytes, × 109/L 811.23 ± 483.58 433.50 752.00 1034.25
Eosinophils, × 109/L 839.02 ± 777.93 321.75 619.00 1148.50
Lymphocytes, × 109/L 5063.21 ± 2353.83 3319.25 4776.00 6292.25
PLATELETS
Platelets, × 109/L 405.54 ± 158.25 286.00 385.00 502.75
HEMOLYSIS
LDH, U/L 856.41 ± 501.60 444.50 721.00 1256.00
AST, U/L 28.25 ± 21.20 15.00 24.00 32.00
Total Bilirubin, g/dL 2.75 ± 1.77 1.40 2.40 3.70
Direct Bilirubin, g/dL 0.67 ± 0.48 0.35 0.60 0.90
Indirect Bilirubin, /dL 2.08 ± 1.58 0.90 1.70 2.85
HEPATIC FUNCTION
ALT, U/L 48.43 ± 25.31 30.75 24.00 32.00
Total proteins, g/dL 7.33± 0.84 6.80 7.30 7.90
Albumin, g/dL 4.06 ± 0.68 3.60 4.20 4.40
Globulin, g/dL 3.27 ± 0.78 2.75 3.30 3.80
Ratio Albumin/Globulin 1.34 ± 0.46 1.00 1.30 1.5
KIDNEY FUNCTION
Urea, mg/dL 17.73 ± 6.40 14.00 16.50 20.00
Creatinine, mg/dL 0.47 ± 0.18 0.40 0.50 0.55
LIPID METABOLISM
Total Cholesterol, mg/dL 121.27 ± 26.04 103.00 119.00 135.00
HDL-C, mg/dL 35.55 ± 12.39 27.00 33.00 43.00
LDL-C, mg/dL 64.80 ± 22.13 50.50 61.00 78.00
VLDL-c, g/dL 20.83 ± 10.02 14.00 18.00 24.00
Triglycerides, g/dL 104.05 ± 50.10 71.75 91.00 118.00
IRON METABOLISM
Ferritin, ng/mL 374.86 ± 320.16 94.90 182.35 399.37
Serum Iron, mcg/dL 122.27 ± 119.39 71.00 10.00 137.75
INFLAMMATION
Antistreptolysin O, UI/mL 282.86 ± 191.25 29.15 94.00 200.00
CRP, mg/L 11.80 ± 6.98 1.33 3.73 7.35
AAT, mg/dL 152.36 ± 46.01 124.00 156.00 186.00
RBC, Red blood cells; MCV, Mean Corpuscular Volume; MCH, Mean Corpuscular Hemoglobin; MCHC, Mean Corpuscular Hemoglobin Concentration; LDH, Lactate Dehydrogenase;
AST, Aspartate Transaminase; ALT, Alanine Transaminase; HDL, High Density Lipoprotein Cholesterol; LDL-C, Low density lipoprotein cholesterol; VLDL, Very low density lipoprotein;
CRP, C-reactive protein; AAT, Alpha-1 antitrypsin.
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TABLE 3 | Profile of the microorganisms identified in the analysis of
specimens isolated from the nasopharynx and oropharynx of patients
with sickle cell disease (SCD).
SCD
patients
N (%)
Sickle cell
anemia patients
N (%)
SC disease
patients
N (%)
MICROORGANISMS ISOLATED FROM NASOPHARYNGEAL SPECIMENS
0-Normal Microbiota 69 (48.2) 43 (43.4) 26 (59.1)
1-Staphylococcus aureus 64 (44.8) 46 (46.5) 18 (40.9)
2-Streptococcus pneumoniae 8 (5.6) 8 (8) 0 (0)
3-Staphylococcus aureus 1 (0.7) 1 (1) 0 (0)
Streptococcus pyogenes
4-Streptococcus pyogenes 1 (0.7) 1 (1) 0 (0)
Total 143 (100) 99 (100) 44 (100)
MICROORGANISMS ISOLATED FROM OROPHARYNGEAL SPECIMENS
0-Normal Microbiota 91 (63.6) 65 (66) 26 (59)
1-Streptococcus pyogenes 20 (14) 13 (13) 7 (16)
2-Streptococcus pneumoniae 8 (5.6) 5 (5) 3 (6.8)
3-Enterobacter gergoviae 1 (0.7) 1 (1) 0 (0)
4-Staphylococcus aureus 17 (11.9) 11 (11) 6 (13.6)
5-Klebsiella pneumoniae 2 (1.4) 1 (1) 1 (2.3)
6-Enterobacter aerogenes 1 (0.7) 1 (1) 0 (0)
7-Pseudomonas aeruginosa 3 (2.1) 2 (2) 1 (2.3)
Total 143 (100) 99 (100) 44 (100)
SCD, sickle cell disease.
(p < 0.0001). The analysis also revealed significant differences
when comparing ferritin values in individuals colonized by
normal microbiota and individuals colonized by S. pneumoniae
(p < 0.0001) (Figure 1).
Statistical analysis of alanine transaminase (ALT)-values (U/L)
revealed significant differences with a mean and standard
deviation of 48.42 ± 22.19 for subjects colonized by normal
microbiota (69/143); 48.38 ± 28.55 for individuals colonized
by S. aureus (64/143); and 85.50 ± 29.22 for individuals
colonized by S. pneumoniae (8/143) (p = 0.02). The analysis
also revealed significant differences when comparing ALT-values
in individuals colonized by normal microbiota and individuals
colonized by S. pneumoniae (p= 0.002) (Figure 2).
Statistical analysis of aspartate transaminase (AST) values
(U/L) revealed significant differences with a mean and standard
deviation of 26.21 ± 16.76 for subjects colonized by normal
microbiota (693/143); 28.02± 21.87 for individuals colonized by
S. aureus (64/141); and 79.25 ± 43.15 for individuals colonized
by S. pneumoniae (8/143) (p< 0.0001). The analysis also revealed
significant differences when comparing AST values in individuals
colonized by normal microbiota and individuals colonized by S.
pneumoniae (p < 0.0001) (Figure 2).
The multivariate analysis adjusted for age and sex found
that infection was independently associated to oropharynx
colonization (P = 0.003; OR = 4.9; 95% IC 1.7–14.0) and
leukocyte count (P = 0.0046; OR = 8.8; 95% IC 1.9–39.9)
(Table 5), and that pneumonia was independently associated to
hemoglobin profile (P = 0.006; OR = 4.3; 95% IC 1.5–12.5)
(Table 6).
TABLE 4 | Antibiogram and serotype profiles of Streptococcus pneumonia isolated from nasopharyngeal (Naso) and oropharyngeal (Oro) specimens from
patients with sickle cell disease.
Patients Specimen origin Penicillin (E-test) Cefaloxine (E-test) SMX /TMP Erythromycin Clindamycin Serotype
1 Naso S S R*** S** S NT*
2 Naso S S R S S 19F
3 Oro S S R S S 19F
4 Oro S S S S S 23F
5 Naso S S S S S 4
6 Naso S S R S S 19A
7 Naso S S R S S 14
8 Naso S S R S S 14
9 Naso S S R S S 14
10 Oro S S R S S 12F
11 Oro S S R S S 9V
12-1# Oro col 1 S S R S S 23F
12-2# Oro col 2 S S R S S 3
13 Naso S S R S S 19F
14 Oro S S R S S 23F
15 Oro S S S S S 23F
16 Oro S S S S S 23A
*NT, not typed; **S, sensitive; ***R, Resistant; # Patient colonized by two serotypes.
SMX/TMP, sulfamethoxazole/trimethoprim; Naso, nasopharyngeal; Oro, oropharyngeal.
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FIGURE 1 | Graphical representation of the analysis of sickle cell anemia patients’ oropharyngeal and nasopharyngeal colonization by normal
microbiota, Staphylococcus aureus, and Streptococcus pneumoniae and by its association with ferritin values (ng /mL). (A) Comparison of ferritin levels
among normal Microbiota, S. pneumonia, and S. aureus in oropharyngeal colonization. (B) Comparison of ferritin levels between normal Microbiota and S.
pneumoniae in oropharyngeal colonization. (C) Comparison of ferritin levels between normal Microbiota and S. aureus oropharyngeal colonization. (D) Comparison of
ferritin levels among normal Microbiota, S. pneumonia, and S. aureus in nasopharyngeal colonization. (E) Comparison of ferritin levels between normal Microbiota and
S. pneumoniae in nasopharyngeal colonization. (F) Comparison of ferritin levels between Normal Microbiota and S. aureus nasopharyngeal colonization. S. aureus,
Staphylococcus aureus; S. pneumonia, Streptococcus pneumoniae; NS, Not significant.
DISCUSSION
The SCD has a high prevalence worldwide with clinical variability
and a variety of factors modulating the disease phenotype; these
factors make understanding patient characteristics fundamental
to improving patient care and to modifying the natural
history of the disease (Quinn et al., 2004; Williams et al.,
2009).
Infections caused by S. pneumoniae are a major cause of
morbidity and mortality in children worldwide, particularly in
children under 5 years old, and are frequent in individuals
with chronic cardiopulmonary diseases and in elderly and
immunocompromised individuals (Hausdorff et al., 2000).
Similarly, the incidence of S. aureus infections are increasing
and are now considered a public health problem in the United
States of America (Denno et al., 2002; Bogaert et al., 2004b;
Cardozo et al., 2006). Although an early onset of prophylaxis with
Penicillin and a proper treatment of the infections have increased
the overall survival in childhood (Iughetti et al., 2016). Given
the high susceptibility to pneumococcal infection, children with
SCD are routinely immunized with pneumococcal vaccines and
administered prophylactic antibiotics alongside (Mitchell and
Mitchell, 2014).
In the current study, we observed nasopharyngeal/oropharynx
colonization by S. pneumoniae in 11.2% of SCD patients and by
S. aureus in 56.7% of SCD patients. Steele et al. (1996) observed
nasopharyngeal colonization by S. pneumonia in 33% of children
with SCD who were under two years of age; in 10% of children 2–
5 years of age; and in 6% of children 5 years of age. These results
were similar to those described by Norris et al. (1996). Fonseca
et al. (2005) reported a prevalence of 13.3% for nasopharyngeal
colonization by S. pneumoniae among Brazilian children with
SCD in São Paulo. We emphasize that none of the studies cited
above included a description of colonization by other pathogens.
Results obtained in this study allow us to hypothesize that
a reduction in nasopharyngeal colonization most likely occurs
secondarily to proper use of pneumococcal vaccines suggesting
the likely effectiveness of vaccination coverage for serotypes that
cause invasive disease. In addition, the S. aureus colonization
results suggest a possible role of nasopharyngeal colonization
by this microorganism in SCD in the children investigated
in this study. A similar role has been was suggested by Lee
et al. (2009) who studied the epidemiology of and risk factors
for colonization with S. aureus in children in Massachusetts
(USA) and concluded that colonization by methicillin-resistant
S. aureus remained stable among children from 2003 to 2004
Frontiers in Microbiology | www.frontiersin.org 6 February 2017 | Volume 8 | Article 217
Rocha et al. Microbiota in Sickle Cell Disease
FIGURE 2 | Graphical representation of the analysis of sickle cell anemia patients nasopharyngeal colonization by normal microbiota, Staphylococcus
aureus, and Streptococcus pneumoniae and its association with biochemical variables. (A) Comparison of alanine aminotransferase levels among normal
Microbiota, S. aureus, and S. pneumoniae nasopharyngeal colonization. (B) Comparison of alanine aminotransferase levels between normal Microbiota and
S. pneumoniae nasopharyngeal colonization. (C) Comparison of aspartate aminotransferase levels among normal Microbiota, S. aureus, and S. pneumoniae
nasopharyngeal colonization. (D) Comparison of aspartate aminotransferase levels between normal Microbiota and S. pneumoniae nasopharyngeal colonization.
S. aureus, Staphylococcus aureus; S. pneumonia, Streptococcus pneumoniae.
TABLE 5 | Multivariate analyses models in sickle cell disease patients with infection as the dependent variable.
Variables Coefficient Standard error Wald test P-value Odds ratio 95% Confidence limits
Oropharynx colonization 1.5902 0.5374 8.7557 0.0031 4.9048 1.7107–14.0628
Neutrophils −1.5627 0.7895 3.9177 0.478 0.2096 0.446–0.9848
Leukocytes 2.1797 0.7687 8.0398 0.0046 8.8439 1.9602–39.9025
Platelets 0.0416 0.5254 0.0063 0.9369 1.0425 0.1554–1.2470
Hemoglobin profile 0.6092 0.6239 0.9532 0.3289 1.8389 0.5413–6.2467
Age 0.4699 0.5334 0.7763 0.3783 1.5999 0.5625–4.5507
Sex 0.6091 0.4652 1.7142 0.1904 1.8388 0.7388–4.5764
Reticulocytes −0.8204 0.5312 2.3854 0.1225 0.4402 0.1554–1.2470
Bold values represent the statistical significant results.
and from 2006 to 2007 despite the widespread use of the
pneumococcal conjugate vaccine. Nasal colonization varied
with age and was inversely proportional to the recent use of
antibiotics.
The profile of pneumococcal strain sensitivity described in
the present study revealed no increase in resistance to penicillin
compared to data obtained in previous studies in Brazil that
included invasive and colonizing strains (Baynes et al., 1986;
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TABLE 6 | Multivariate analyses models in sickle cell disease patients with pneumonia as the dependent variable.
Variables Coefficient Standard error Wald-test P-values Odds ratio 95% confidence limits
Neutrophils −0.1696 0.5890 0.8293 0.7733 0.8440 0.2661–2.6772
Platelets 0.5888 0.4361 1.8229 0.1770 1.8017 0.7665–4.2351
Reticulocytes 0.1406 0.4469 0.0990 0.7531 1.1510 0.4793–2.7637
Leukocytes 0.3156 0.6099 0.2677 0.6048 1.3711 0.4149–4.5310
Hemoglobin profile 1.4699 0.5403 7.4010 0.0065 4.3489 1.5082–12.5398
Oropharynx colonization 0.3235 0.4269 0.5741 0.4486 1.3819 0.5985–3.1906
Neutrophils −0.1310 0.5862 0.0500 0.8231 0.8772 0.2781–2.7671
Platelets 0.5964 0.4360 1.8713 0.1713 1.8156 0.7725–4.2670
Reticulocytes 0.1431 0.4450 0.1034 0.7478 1.1538 0.4823–2.7603
Leukocytes 0.3091 0.6092 0.2574 0.6119 1.3622 0.4127–4.4961
Hemoglobin profile 1.4423 0.4116 7.0774 0.0078 4.2303 1.4618–12.2418
Nasopharynx colonization −0.0240 0.4528 0.0034 0.9535 0.9763 0.4357–2.1875
Bold values represent the statistical significant results.
Moran et al., 2005; Marchese et al., 2011). However, the
pneumococcal penicillin sensitivity results presented in this study
corroborate those reported by Fonseca et al. (2005) who analyzed
98 Brazilian children from São Paulo and suggested that penicillin
remains safe for both prophylaxis and treatment in children
with SCD. The authors reported high pneumococcal resistance
to clotrimoxazol (sulfamethoxazole/trimethoprim (SMX/TRP)
combination) that was 64%. These results suggest that this
antibiotic should be used with caution for the treatment of
S. pneumoniae infections in patients similar to those included in
this study.
Most of the identified strains of S. pneumoniae were from
serotypes that cause invasive diseases in Brazil (Berezin et al.,
2002; Mantese et al., 2003). In the present study, we observed
the presence of serotypes that dominate in reports of infections
in children worldwide (i.e., 6, 14, 19, 23) (Sniadack et al., 1995)
with the exception that we did not identify serotype 6. Marchese
et al. (2011) evaluated blood cultures from children up to 5 years
of age in Italy who were hospitalized for community-acquired
pneumonia and identified serotypes 19A and 14 more frequently
than other serotypes corroborating the results reported in the
present study. Brandileone et al. (1998) reported that infections
caused by serotypes 1 and 5 are common in our country;
however, in the present study, these serotypes were not isolated
corroborating the results reported by Fonseca et al. (2005)
and comments made by Berezin et al. (2002) who considered
these serotypes significant in the context of nasopharyngeal
colonization.
Chemical and hematological measurements are important for
monitoring the clinical course of disease in patients with SCD.
Children with HbSS exhibited significant differences in almost
all analyses when compared to the HbSC group corroborating
the results presented by Seixas et al. (2010) who studied children
with SCD from the same population. These results also confirm
existing data in the literature related to the clinical severity of
HbSS compared to other types of SCD (Steinberg and Rodgers,
2001).
Among the biochemical markers analyzed in this study,
those associated with inflammation, haemolysis, infection, and
oxidative stress were highlighted with an emphasis on patients
who exhibited serum ferritin concentrations above the mean
values established for the group (≥320.16). Because this protein
increases during inflammatory and infectious processes, an
accumulation of iron may occur in these patients (Rogers,
1996). SCD is characterized by a proinflammatory state with the
presence of abnormal endothelial activation (Belcher et al., 2014).
At baseline, ferritin is an important protein for maintaining
iron stores in the body. However, during the inflammatory
processes, ferritin is regulated by hepcidin and interleukin-6 (IL-
6) levels. Other proinflammatory cytokines, such as IL-1β and
tumor necrosis factor alpha (TNF-α), also indirectly induce the
synthesis of ferritin because they increase the incorporation of
iron by hepatocytes (Baynes et al., 1986; Jurado, 1997). The
association of a chronic inflammatory state with the observation
of increased ferritin values in SCD patients colonized by
microorganisms can serve as a marker of clinical severity.
It is known that encapsulated bacteria, in particular S.
pneumoniae, have a polysaccharide capsule that impedes binding
of complement or prevents complement assembled on the cell
wall from interacting with macrophage receptors (Bohnsack and
Brown, 1986). On the other hand, macrophages engulfing the
abnormally sickle shaped cells may become “blocked,” impairing
their phagocytosis of other particles, which may contribute to
the infection prolongation (Booth et al., 2010). McCavit et al.
(2011) described seven invasive pneumococcal diseases due to
non-vaccinal serotypes on SCD patients after the pneumococcal
7-valent conjugate vaccine. These facts allow us to suggest that
both inflammation and colonization processes are responsible for
the abnormal ferritin levels found in our patients.
The results presented in this study demonstrate that patients
whose nasopharynx is colonized by S. pneumoniae exhibit high
levels of AST, ALT, and ferritin. These associations demonstrate
that routine biochemical evaluations and assessments of
nasopharynx colonization may be important when monitoring
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the clinical course of SCD patients. The significant differences
observed in this study suggest that the colonization by
microorganisms is involved in the modulation of inflammatory
events in these patients; the presence of pathogens may increase
reactive oxidative species maintaining the inflammatory state and
increasing disease severity. Unfortunately, we did not compare
our findings with previous reports because no similar data were
available in the literature.
Studies of the colonization of the nasopharynx and
oropharynx by microorganisms in children with SCD can
provide important information for public health programs,
avoiding severe infections. However, the finding of altered levels
of molecules associated with hemolysis and inflammation among
SCD individuals with nasopharynx and oropharynx colonization
emphasizes the need to elucidate the mechanisms that may
determine the development of an invasive infection disease,
since the influence of colonization on therapeutic and vaccine
effectiveness are poorly understood. Moreover, it is important
to clarify the mechanisms by which the biomarkers involved
are associated with the presence of these microorganisms
and inflammatory processes among SCD patients. This type
of information would improve our understanding of these
processes and the clinical prognosis in these patients.
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